APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Molecular Diagnostics Raw Material

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Molecular Diagnostics Raw Material Market Analysis and Forecast 2026-2032

Report ID 174013980230 December 2025198 pages

Choose your research edition.

Industry ResearchMolecular Diagnostics Raw Material Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Molecular Diagnostics Raw Material Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Molecular Diagnostics Raw Material Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molecular Diagnostics Raw Material Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Molecular Diagnostics Raw Material Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Molecular Diagnostics Raw Material market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Molecular Diagnostics Raw Material is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Molecular Diagnostics Raw Material is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Molecular Diagnostics Raw Material is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Molecular Diagnostics Raw Material is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Molecular Diagnostics Raw Material include Agilent, Bio-Rad, Fapon Biotech, New England Biolabs, Promega, Qiagen, Takara Bio, TOYOBO Biotech and Fapon Biotech Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Molecular Diagnostics Raw Material, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Molecular Diagnostics Raw Material, also provides the revenue of main regions and countries. Of the upcoming market potential for Molecular Diagnostics Raw Material, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Molecular Diagnostics Raw Material revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Molecular Diagnostics Raw Material market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Molecular Diagnostics Raw Material revenue, projected growth trends, production technology, application and end-user industry.

Molecular Diagnostics Raw Material Segment by Company

Agilent

Bio-Rad

Fapon Biotech

New England Biolabs

Promega

Qiagen

Takara Bio

TOYOBO Biotech

Fapon Biotech Inc

Roche

Vazyme

Thermo Fisher

Molecular Diagnostics Raw Material Segment by Type

DNA Polymerase

PCR Excipients

Reverse Transcriptase

Other

Molecular Diagnostics Raw Material Segment by Application

scientific Research

Disease Diagnosis

Adjuvant Therapy

Molecular Diagnostics Raw Material Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Diagnostics Raw Material market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Diagnostics Raw Material and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Diagnostics Raw Material.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Molecular Diagnostics Raw Material in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Molecular Diagnostics Raw Material company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Diagnostics Raw Material revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Molecular Diagnostics Raw Material Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. DNA Polymerase Major Player Table 3. PCR Excipients Major Player Table 4. Reverse Transcriptase Major Player Table 5. Other Major Player Table 6. Global Molecular Diagnostics Raw Material Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. scientific Research Major Player Table 8. Disease Diagnosis Major Player Table 9. Adjuvant Therapy Major Player Table 10. Molecular Diagnostics Raw Material Industry Trends Table 11. Molecular Diagnostics Raw Material Industry Drivers Table 12. Molecular Diagnostics Raw Material Industry Opportunities and Challenges Table 13. Molecular Diagnostics Raw Material Industry Restraints Table 14. Global Molecular Diagnostics Raw Material Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Molecular Diagnostics Raw Material Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Molecular Diagnostics Raw Material Market Share by Region (2021-2026) Table 17. Global Molecular Diagnostics Raw Material Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Molecular Diagnostics Raw Material Market Share by Region (2027-2032) Table 19. Global Molecular Diagnostics Raw Material Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Molecular Diagnostics Raw Material Revenue Market Share by Players (2021-2026) Table 21. Global Molecular Diagnostics Raw Material Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Molecular Diagnostics Raw Material Key Players Headquarters & Area Served Table 23. Global Molecular Diagnostics Raw Material Players, Product Type & Application Table 24. Global Molecular Diagnostics Raw Material Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Molecular Diagnostics Raw Material by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Molecular Diagnostics Raw Material Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Molecular Diagnostics Raw Material Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Molecular Diagnostics Raw Material Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Molecular Diagnostics Raw Material Revenue Market Share by Type (2021-2026) Table 31. Global Molecular Diagnostics Raw Material Revenue Market Share by Type (2027-2032) Table 32. Global Molecular Diagnostics Raw Material Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Molecular Diagnostics Raw Material Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Molecular Diagnostics Raw Material Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Molecular Diagnostics Raw Material Revenue Market Share by Application (2021-2026) Table 36. Global Molecular Diagnostics Raw Material Revenue Market Share by Application (2027-2032) Table 37. Agilent Company Information Table 38. Agilent Business Overview Table 39. Agilent Molecular Diagnostics Raw Material Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Agilent Molecular Diagnostics Raw Material Product Portfolio Table 41. Agilent Recent Development Table 42. Bio-Rad Company Information Table 43. Bio-Rad Business Overview Table 44. Bio-Rad Molecular Diagnostics Raw Material Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Bio-Rad Molecular Diagnostics Raw Material Product Portfolio Table 46. Bio-Rad Recent Development Table 47. Fapon Biotech Company Information Table 48. Fapon Biotech Business Overview Table 49. Fapon Biotech Molecular Diagnostics Raw Material Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Fapon Biotech Molecular Diagnostics Raw Material Product Portfolio Table 51. Fapon Biotech Recent Development Table 52. New England Biolabs Company Information Table 53. New England Biolabs Business Overview Table 54. New England Biolabs Molecular Diagnostics Raw Material Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. New England Biolabs Molecular Diagnostics Raw Material Product Portfolio Table 56. New England Biolabs Recent Development Table 57. Promega Company Information Table 58. Promega Business Overview Table 59. Promega Molecular Diagnostics Raw Material Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Promega Molecular Diagnostics Raw Material Product Portfolio Table 61. Promega Recent Development Table 62. Qiagen Company Information Table 63. Qiagen Business Overview Table 64. Qiagen Molecular Diagnostics Raw Material Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Qiagen Molecular Diagnostics Raw Material Product Portfolio Table 66. Qiagen Recent Development Table 67. Takara Bio Company Information Table 68. Takara Bio Business Overview Table 69. Takara Bio Molecular Diagnostics Raw Material Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Takara Bio Molecular Diagnostics Raw Material Product Portfolio Table 71. Takara Bio Recent Development Table 72. TOYOBO Biotech Company Information Table 73. TOYOBO Biotech Business Overview Table 74. TOYOBO Biotech Molecular Diagnostics Raw Material Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. TOYOBO Biotech Molecular Diagnostics Raw Material Product Portfolio Table 76. TOYOBO Biotech Recent Development Table 77. Fapon Biotech Inc Company Information Table 78. Fapon Biotech Inc Business Overview Table 79. Fapon Biotech Inc Molecular Diagnostics Raw Material Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Fapon Biotech Inc Molecular Diagnostics Raw Material Product Portfolio Table 81. Fapon Biotech Inc Recent Development Table 82. Roche Company Information Table 83. Roche Business Overview Table 84. Roche Molecular Diagnostics Raw Material Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Roche Molecular Diagnostics Raw Material Product Portfolio Table 86. Roche Recent Development Table 87. Vazyme Company Information Table 88. Vazyme Business Overview Table 89. Vazyme Molecular Diagnostics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Vazyme Molecular Diagnostics Raw Material Product Portfolio Table 91. Vazyme Recent Development Table 92. Thermo Fisher Company Information Table 93. Thermo Fisher Business Overview Table 94. Thermo Fisher Molecular Diagnostics Raw Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Thermo Fisher Molecular Diagnostics Raw Material Product Portfolio Table 96. Thermo Fisher Recent Development Table 97. North America Molecular Diagnostics Raw Material Revenue by Type (2021-2026) & (US$ Million) Table 98. North America Molecular Diagnostics Raw Material Revenue by Type (2027-2032) & (US$ Million) Table 99. North America Molecular Diagnostics Raw Material Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Molecular Diagnostics Raw Material Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Molecular Diagnostics Raw Material Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Molecular Diagnostics Raw Material Revenue by Country (2021-2026) & (US$ Million) Table 103. North America Molecular Diagnostics Raw Material Revenue by Country (US$ Million) & (2027-2032) Table 104. Europe Molecular Diagnostics Raw Material Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Molecular Diagnostics Raw Material Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Molecular Diagnostics Raw Material Revenue by Application (2021-2026) & (US$ Million) Table 107. Europe Molecular Diagnostics Raw Material Revenue by Application (2027-2032) & (US$ Million) Table 108. Europe Molecular Diagnostics Raw Material Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe Molecular Diagnostics Raw Material Revenue by Country (2021-2026) & (US$ Million) Table 110. Europe Molecular Diagnostics Raw Material Revenue by Country (US$ Million) & (2027-2032) Table 111. China Molecular Diagnostics Raw Material Revenue by Type (2021-2026) & (US$ Million) Table 112. China Molecular Diagnostics Raw Material Revenue by Type (2027-2032) & (US$ Million) Table 113. China Molecular Diagnostics Raw Material Revenue by Application (2021-2026) & (US$ Million) Table 114. China Molecular Diagnostics Raw Material Revenue by Application (2027-2032) & (US$ Million) Table 115. Asia Molecular Diagnostics Raw Material Revenue by Type (2021-2026) & (US$ Million) Table 116. Asia Molecular Diagnostics Raw Material Revenue by Type (2027-2032) & (US$ Million) Table 117. Asia Molecular Diagnostics Raw Material Revenue by Application (2021-2026) & (US$ Million) Table 118. Asia Molecular Diagnostics Raw Material Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Molecular Diagnostics Raw Material Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Asia Molecular Diagnostics Raw Material Revenue by Region (US$ Million) & (2021-2026) Table 121. Asia Molecular Diagnostics Raw Material Revenue by Region (US$ Million) & (2027-2032) Table 122. SAMEA Molecular Diagnostics Raw Material Revenue by Type (2021-2026) & (US$ Million) Table 123. SAMEA Molecular Diagnostics Raw Material Revenue by Type (2027-2032) & (US$ Million) Table 124. SAMEA Molecular Diagnostics Raw Material Revenue by Application (2021-2026) & (US$ Million) Table 125. SAMEA Molecular Diagnostics Raw Material Revenue by Application (2027-2032) & (US$ Million) Table 126. SAMEA Molecular Diagnostics Raw Material Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. SAMEA Molecular Diagnostics Raw Material Revenue by Country (2021-2026) & (US$ Million) Table 128. SAMEA Molecular Diagnostics Raw Material Revenue by Country (US$ Million) & (2027-2032) Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Molecular Diagnostics Raw Material Image Figure 2. Global Molecular Diagnostics Raw Material Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molecular Diagnostics Raw Material Market Size Share 2021 VS 2025 VS 2032 Figure 4. DNA Polymerase Image Figure 5. PCR Excipients Image Figure 6. Reverse Transcriptase Image Figure 7. Other Image Figure 8. Global Molecular Diagnostics Raw Material Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Molecular Diagnostics Raw Material Market Size Share 2021 VS 2025 VS 2032 Figure 10. scientific Research Image Figure 11. Disease Diagnosis Image Figure 12. Adjuvant Therapy Image Figure 13. Global Molecular Diagnostics Raw Material Market Size (US$ Million) & (2021-2032) Figure 14. Global Molecular Diagnostics Raw Material Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Molecular Diagnostics Raw Material Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Molecular Diagnostics Raw Material Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Molecular Diagnostics Raw Material Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Molecular Diagnostics Raw Material Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Molecular Diagnostics Raw Material Revenue Market Share by Type (2021-2032) Figure 21. Global Molecular Diagnostics Raw Material Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Molecular Diagnostics Raw Material Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Molecular Diagnostics Raw Material Revenue Market Share by Application (2021-2032) Figure 24. North America Molecular Diagnostics Raw Material Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Molecular Diagnostics Raw Material Revenue Share by Type (2021-2032) Figure 26. North America Molecular Diagnostics Raw Material Revenue Share by Application (2021-2032) Figure 27. North America Molecular Diagnostics Raw Material Revenue Share by Country (2021-2032) Figure 28. United States Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Molecular Diagnostics Raw Material Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Molecular Diagnostics Raw Material Revenue Share by Type (2021-2032) Figure 33. Europe Molecular Diagnostics Raw Material Revenue Share by Application (2021-2032) Figure 34. Europe Molecular Diagnostics Raw Material Revenue Share by Country (2021-2032) Figure 35. Germany Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Molecular Diagnostics Raw Material Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Molecular Diagnostics Raw Material Revenue Share by Type (2021-2032) Figure 45. China Molecular Diagnostics Raw Material Revenue Share by Application (2021-2032) Figure 46. Asia Molecular Diagnostics Raw Material Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Molecular Diagnostics Raw Material Revenue Share by Type (2021-2032) Figure 48. Asia Molecular Diagnostics Raw Material Revenue Share by Application (2021-2032) Figure 49. Asia Molecular Diagnostics Raw Material Revenue Share by Region (2021-2032) Figure 50. Japan Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Molecular Diagnostics Raw Material Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Molecular Diagnostics Raw Material Revenue Share by Type (2021-2032) Figure 58. SAMEA Molecular Diagnostics Raw Material Revenue Share by Application (2021-2032) Figure 59. SAMEA Molecular Diagnostics Raw Material Revenue Share by Country (2021-2032) Figure 60. Brazil Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Molecular Diagnostics Raw Material Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Polymerase
  • PCR Excipients
  • Reverse Transcriptase
  • Other
Applications
  • scientific Research
  • Disease Diagnosis
  • Adjuvant Therapy
Companies covered
  • Agilent
  • Bio-Rad
  • Fapon Biotech
  • New England Biolabs
  • Promega
  • Qiagen
  • Takara Bio
  • TOYOBO Biotech
  • Fapon Biotech Inc
  • Roche
  • Vazyme
  • Thermo Fisher

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Molecular Diagnostics Raw Material Market by Type
  3. 1.2.1 Global Molecular Diagnostics Raw Material Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 DNA Polymerase
  5. 1.2.3 PCR Excipients
  6. 1.2.4 Reverse Transcriptase
  7. 1.2.5 Other
  8. 1.3 Molecular Diagnostics Raw Material Market by Application
  9. 1.3.1 Global Molecular Diagnostics Raw Material Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 scientific Research
  11. 1.3.3 Disease Diagnosis
  12. 1.3.4 Adjuvant Therapy
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Molecular Diagnostics Raw Material Market Dynamics
  1. 2.1 Molecular Diagnostics Raw Material Industry Trends
  2. 2.2 Molecular Diagnostics Raw Material Industry Drivers
  3. 2.3 Molecular Diagnostics Raw Material Industry Opportunities and Challenges
  4. 2.4 Molecular Diagnostics Raw Material Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Molecular Diagnostics Raw Material Market Perspective (2021-2032)
  2. 3.2 Global Molecular Diagnostics Raw Material Growth Trends by Region
  3. 3.2.1 Global Molecular Diagnostics Raw Material Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Molecular Diagnostics Raw Material Market Size by Region (2021-2026)
  5. 3.2.3 Global Molecular Diagnostics Raw Material Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Molecular Diagnostics Raw Material Revenue by Players
  2. 4.1.1 Global Molecular Diagnostics Raw Material Revenue by Players (2021-2026)
  3. 4.1.2 Global Molecular Diagnostics Raw Material Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Molecular Diagnostics Raw Material Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Molecular Diagnostics Raw Material Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Molecular Diagnostics Raw Material Key Players Headquarters & Area Served
  7. 4.4 Global Molecular Diagnostics Raw Material Players, Product Type & Application
  8. 4.5 Global Molecular Diagnostics Raw Material Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Molecular Diagnostics Raw Material Market CR5 and HHI
  11. 4.6.3 2025 Molecular Diagnostics Raw Material Tier 1, Tier 2, and Tier 3
5 Molecular Diagnostics Raw Material Market Size by Type
  1. 5.1 Global Molecular Diagnostics Raw Material Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Molecular Diagnostics Raw Material Revenue by Type (2021-2032)
  3. 5.3 Global Molecular Diagnostics Raw Material Revenue Market Share by Type (2021-2032)
6 Molecular Diagnostics Raw Material Market Size by Application
  1. 6.1 Global Molecular Diagnostics Raw Material Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Molecular Diagnostics Raw Material Revenue by Application (2021-2032)
  3. 6.3 Global Molecular Diagnostics Raw Material Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Agilent
  2. 7.1.1 Agilent Company Information
  3. 7.1.2 Agilent Business Overview
  4. 7.1.3 Agilent Molecular Diagnostics Raw Material Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Agilent Molecular Diagnostics Raw Material Product Portfolio
  6. 7.1.5 Agilent Recent Developments
  7. 7.2 Bio-Rad
  8. 7.2.1 Bio-Rad Company Information
  9. 7.2.2 Bio-Rad Business Overview
  10. 7.2.3 Bio-Rad Molecular Diagnostics Raw Material Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bio-Rad Molecular Diagnostics Raw Material Product Portfolio
  12. 7.2.5 Bio-Rad Recent Developments
  13. 7.3 Fapon Biotech
  14. 7.3.1 Fapon Biotech Company Information
  15. 7.3.2 Fapon Biotech Business Overview
  16. 7.3.3 Fapon Biotech Molecular Diagnostics Raw Material Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Fapon Biotech Molecular Diagnostics Raw Material Product Portfolio
  18. 7.3.5 Fapon Biotech Recent Developments
  19. 7.4 New England Biolabs
  20. 7.4.1 New England Biolabs Company Information
  21. 7.4.2 New England Biolabs Business Overview
  22. 7.4.3 New England Biolabs Molecular Diagnostics Raw Material Revenue and Gross Margin (2021-2026)
  23. 7.4.4 New England Biolabs Molecular Diagnostics Raw Material Product Portfolio
  24. 7.4.5 New England Biolabs Recent Developments
  25. 7.5 Promega
  26. 7.5.1 Promega Company Information
  27. 7.5.2 Promega Business Overview
  28. 7.5.3 Promega Molecular Diagnostics Raw Material Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Promega Molecular Diagnostics Raw Material Product Portfolio
  30. 7.5.5 Promega Recent Developments
  31. 7.6 Qiagen
  32. 7.6.1 Qiagen Company Information
  33. 7.6.2 Qiagen Business Overview
  34. 7.6.3 Qiagen Molecular Diagnostics Raw Material Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Qiagen Molecular Diagnostics Raw Material Product Portfolio
  36. 7.6.5 Qiagen Recent Developments
  37. 7.7 Takara Bio
  38. 7.7.1 Takara Bio Company Information
  39. 7.7.2 Takara Bio Business Overview
  40. 7.7.3 Takara Bio Molecular Diagnostics Raw Material Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Takara Bio Molecular Diagnostics Raw Material Product Portfolio
  42. 7.7.5 Takara Bio Recent Developments
  43. 7.8 TOYOBO Biotech
  44. 7.8.1 TOYOBO Biotech Company Information
  45. 7.8.2 TOYOBO Biotech Business Overview
  46. 7.8.3 TOYOBO Biotech Molecular Diagnostics Raw Material Revenue and Gross Margin (2021-2026)
  47. 7.8.4 TOYOBO Biotech Molecular Diagnostics Raw Material Product Portfolio
  48. 7.8.5 TOYOBO Biotech Recent Developments
  49. 7.9 Fapon Biotech Inc
  50. 7.9.1 Fapon Biotech Inc Company Information
  51. 7.9.2 Fapon Biotech Inc Business Overview
  52. 7.9.3 Fapon Biotech Inc Molecular Diagnostics Raw Material Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Fapon Biotech Inc Molecular Diagnostics Raw Material Product Portfolio
  54. 7.9.5 Fapon Biotech Inc Recent Developments
  55. 7.10 Roche
  56. 7.10.1 Roche Company Information
  57. 7.10.2 Roche Business Overview
  58. 7.10.3 Roche Molecular Diagnostics Raw Material Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Roche Molecular Diagnostics Raw Material Product Portfolio
  60. 7.10.5 Roche Recent Developments
  61. 7.11 Vazyme
  62. 7.11.1 Vazyme Company Information
  63. 7.11.2 Vazyme Business Overview
  64. 7.11.3 Vazyme Molecular Diagnostics Raw Material Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Vazyme Molecular Diagnostics Raw Material Product Portfolio
  66. 7.11.5 Vazyme Recent Developments
  67. 7.12 Thermo Fisher
  68. 7.12.1 Thermo Fisher Company Information
  69. 7.12.2 Thermo Fisher Business Overview
  70. 7.12.3 Thermo Fisher Molecular Diagnostics Raw Material Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Thermo Fisher Molecular Diagnostics Raw Material Product Portfolio
  72. 7.12.5 Thermo Fisher Recent Developments
8 North America
  1. 8.1 North America Molecular Diagnostics Raw Material Revenue (2021-2032)
  2. 8.2 North America Molecular Diagnostics Raw Material Revenue by Type (2021-2032)
  3. 8.2.1 North America Molecular Diagnostics Raw Material Revenue by Type (2021-2026)
  4. 8.2.2 North America Molecular Diagnostics Raw Material Revenue by Type (2027-2032)
  5. 8.3 North America Molecular Diagnostics Raw Material Revenue Share by Type (2021-2032)
  6. 8.4 North America Molecular Diagnostics Raw Material Revenue by Application (2021-2032)
  7. 8.4.1 North America Molecular Diagnostics Raw Material Revenue by Application (2021-2026)
  8. 8.4.2 North America Molecular Diagnostics Raw Material Revenue by Application (2027-2032)
  9. 8.5 North America Molecular Diagnostics Raw Material Revenue Share by Application (2021-2032)
  10. 8.6 North America Molecular Diagnostics Raw Material Revenue by Country
  11. 8.6.1 North America Molecular Diagnostics Raw Material Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Molecular Diagnostics Raw Material Revenue by Country (2021-2026)
  13. 8.6.3 North America Molecular Diagnostics Raw Material Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Molecular Diagnostics Raw Material Revenue (2021-2032)
  2. 9.2 Europe Molecular Diagnostics Raw Material Revenue by Type (2021-2032)
  3. 9.2.1 Europe Molecular Diagnostics Raw Material Revenue by Type (2021-2026)
  4. 9.2.2 Europe Molecular Diagnostics Raw Material Revenue by Type (2027-2032)
  5. 9.3 Europe Molecular Diagnostics Raw Material Revenue Share by Type (2021-2032)
  6. 9.4 Europe Molecular Diagnostics Raw Material Revenue by Application (2021-2032)
  7. 9.4.1 Europe Molecular Diagnostics Raw Material Revenue by Application (2021-2026)
  8. 9.4.2 Europe Molecular Diagnostics Raw Material Revenue by Application (2027-2032)
  9. 9.5 Europe Molecular Diagnostics Raw Material Revenue Share by Application (2021-2032)
  10. 9.6 Europe Molecular Diagnostics Raw Material Revenue by Country
  11. 9.6.1 Europe Molecular Diagnostics Raw Material Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Molecular Diagnostics Raw Material Revenue by Country (2021-2026)
  13. 9.6.3 Europe Molecular Diagnostics Raw Material Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Molecular Diagnostics Raw Material Revenue (2021-2032)
  2. 10.2 China Molecular Diagnostics Raw Material Revenue by Type (2021-2032)
  3. 10.2.1 China Molecular Diagnostics Raw Material Revenue by Type (2021-2026)
  4. 10.2.2 China Molecular Diagnostics Raw Material Revenue by Type (2027-2032)
  5. 10.3 China Molecular Diagnostics Raw Material Revenue Share by Type (2021-2032)
  6. 10.4 China Molecular Diagnostics Raw Material Revenue by Application (2021-2032)
  7. 10.4.1 China Molecular Diagnostics Raw Material Revenue by Application (2021-2026)
  8. 10.4.2 China Molecular Diagnostics Raw Material Revenue by Application (2027-2032)
  9. 10.5 China Molecular Diagnostics Raw Material Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Molecular Diagnostics Raw Material Revenue (2021-2032)
  2. 11.2 Asia Molecular Diagnostics Raw Material Revenue by Type (2021-2032)
  3. 11.2.1 Asia Molecular Diagnostics Raw Material Revenue by Type (2021-2026)
  4. 11.2.2 Asia Molecular Diagnostics Raw Material Revenue by Type (2027-2032)
  5. 11.3 Asia Molecular Diagnostics Raw Material Revenue Share by Type (2021-2032)
  6. 11.4 Asia Molecular Diagnostics Raw Material Revenue by Application (2021-2032)
  7. 11.4.1 Asia Molecular Diagnostics Raw Material Revenue by Application (2021-2026)
  8. 11.4.2 Asia Molecular Diagnostics Raw Material Revenue by Application (2027-2032)
  9. 11.5 Asia Molecular Diagnostics Raw Material Revenue Share by Application (2021-2032)
  10. 11.6 Asia Molecular Diagnostics Raw Material Revenue by Country
  11. 11.6.1 Asia Molecular Diagnostics Raw Material Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Molecular Diagnostics Raw Material Revenue by Country (2021-2026)
  13. 11.6.3 Asia Molecular Diagnostics Raw Material Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Molecular Diagnostics Raw Material Revenue (2021-2032)
  2. 12.2 SAMEA Molecular Diagnostics Raw Material Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Molecular Diagnostics Raw Material Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Molecular Diagnostics Raw Material Revenue by Type (2027-2032)
  5. 12.3 SAMEA Molecular Diagnostics Raw Material Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Molecular Diagnostics Raw Material Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Molecular Diagnostics Raw Material Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Molecular Diagnostics Raw Material Revenue by Application (2027-2032)
  9. 12.5 SAMEA Molecular Diagnostics Raw Material Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Molecular Diagnostics Raw Material Revenue by Country
  11. 12.6.1 SAMEA Molecular Diagnostics Raw Material Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Molecular Diagnostics Raw Material Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Molecular Diagnostics Raw Material Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst